The estimated Net Worth of Kenneth S Siegel is at least $1.08 Milione dollars as of 13 August 2019. Mr. Siegel owns over 25,606 units of SenesTech Inc stock worth over $82,195 and over the last 6 years he sold SNES stock worth over $0. In addition, he makes $996,476 as Chief Executive Officer e Director at SenesTech Inc.
Sign up
Mr. Siegel SNES stock SEC Form 4 insiders trading
Kenneth has made over 3 trades of the SenesTech Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 25,606 units of SNES stock worth $82,195 on 13 August 2019.
The largest trade he's ever made was buying 696,296 units of SenesTech Inc stock on 16 July 2019 worth over $940,000. On average, Kenneth trades about 80,907 units every 6 days since 2018. As of 13 August 2019 he still owns at least 25,606 units of SenesTech Inc stock.
You can see the complete history of Mr. Siegel stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Kenneth Siegel biography
Kenneth Siegel J.D. serves as Chief Executive Officer, Director of the Company. Mr. Siegel has over 25 years of experience as an executive and senior leader of major corporations. From December 2016 to November 2018, Mr. Siegel served in key leadership roles at Diamond Resorts International Inc., a global vacation ownership company, most recently as President since March 2017. Prior to Diamond Resorts, he served as Chief Administrative Officer and General Counsel of Starwood Hotels & Resorts, a branded lifestyle hospitality company. An instrumental member of the Starwood leadership team, Mr. Siegel was intimately involved in Starwood’s emergence as an industry leader before its acquisition by Marriott International in 2016. Part of Mr. Siegel’s role included leading Starwood’s Corporate Social Responsibility Programs. He introduced industry-leading initiatives in sustainability, energy and water conservation and education. He implemented numerous programs to reduce the Company’s impact on the planet and became a passionate advocate for methods that could be both effective and environmentally sustainable. Prior to joining Starwood in 2000, Mr. Siegel spent four years as the Senior Vice President and General Counsel of Cognizant Corporation and its successor companies. Mr. Siegel also serves as a member of the Board of Directors of Babcock & Wilcox Enterprises, Inc. Mr. Siegel has a bachelor’s degree from Cornell University and a juris doctorate degree from New York University.
What is the salary of Kenneth Siegel?
As the Chief Executive Officer e Director of SenesTech Inc, the total compensation of Kenneth Siegel at SenesTech Inc is $996,476. There are no executives at SenesTech Inc getting paid more.
How old is Kenneth Siegel?
Kenneth Siegel is 64, he's been the Chief Executive Officer e Director of SenesTech Inc since 2019. There are 3 older and 10 younger executives at SenesTech Inc. The oldest executive at SenesTech Inc is Marc Dumont, 76, who is the Independent Director.
What's Kenneth Siegel's mailing address?
Kenneth's mailing address filed with the SEC is C/O SENESTECH, INC., 23460 N. 19TH AVE., STE 110, PHOENIX, AZ, 85027.
Insiders trading at SenesTech Inc
Over the last 8 years, insiders at SenesTech Inc have traded over $262,233 worth of SenesTech Inc stock and bought 999,146 units worth $1,973,633 . The most active insiders traders include Grover T Wickersham, Kenneth S Siegel e Jacob Steven Leach. On average, SenesTech Inc executives and independent directors trade stock every 24 days with the average trade being worth of $74,077. The most recent stock trade was executed by Jacob Steven Leach on 16 August 2021, trading 150,000 units of SNES stock currently worth $229,500.
What does SenesTech Inc do?
senestech is changing the paradigm of pest management by targeting the root cause of the problem: reproduction. contrapest® is an innovative technology that targets the reproductive capabilities of norway and roof rats. as a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down. our delivery system is designed to minimize handler exposure, and contrapest® is dispensed inside tamper resistant bait stations, minimizing the risks to non-target species. as a versatile tool, contrapest® can be used within your integrated pest management program to help reduce reproduction and magnify the success of your ipm protocols or as a standalone, non-lethal solution for customers that are looking to reduce or eliminate their use of lethal methodologies. contrapest® is a restricted use pesticide, due to applicator expertise. please read and comply with all label instructions. fo
What does SenesTech Inc's logo look like?
Complete history of Mr. Siegel stock trades at SenesTech Inc e Babcock & Wilcox Enterprises Inc
SenesTech Inc executives and stock owners
SenesTech Inc executives and other stock owners filed with the SEC include:
-
Kenneth Siegel,
Chief Executive Officer, Director -
Kenneth S. Siegel,
CEO & Director -
Thomas Chesterman,
Chief Financial Officer, Executive Vice President, Treasurer, Assistant Secretary -
Thomas C. Chesterman M.B.A.,
Exec. VP, CFO, Treasurer & Assistant Sec. -
Thomas C. Chesterman,
Exec. VP, CFO, Treasurer & Assistant Sec. -
Dr. Steven C. Krause Ph.D.,
Exec. VP of Sales & Marketing -
Kim Wolin,
Executive Vice President - Operations, Secretary -
Jamie Morrison,
Independent Chairman of the Board -
Kim Patrice Wolin,
Exec. VP of Operations & Sec. -
Jake Leach,
Independent Director -
K. Kavanagh,
Independent Director -
Phil Grandinetti,
Independent Director -
Julia Williams,
Independent Director -
Matthew Szot,
Independent Director -
Marc Dumont,
Independent Director -
Delphine Chiavarini,
Independent Director -
Steve Krause,
Executive Vice President of Sales and Marketing -
Nicole Williams,
Chief Strategy Officer -
Robert Blum,
Investor Relations -
Paul M. Palz,
VP & Corp. Controller -
Loretta Powers Mayer,
Chief Scientific Officer -
Grover T Wickersham,
Director -
Robert E Jr Ramsey,
Director -
Cheryl Ann Dyer,
Pres. & Chief Research Officer -
Jacob Steven Leach,
Director -
Nicole C Williams,
Chief Strategy Officer -
Joel Lee Fruendt,
Chief Executive Officer